相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Kinome expression profiling to target new therapeutic avenues in multiple myeloma
Hugues de Boussac et al.
HAEMATOLOGICA (2020)
A Role for p53 in the Adaptation to Glutamine Starvation through the Expression of SLC1A3
Mylene Tajan et al.
CELL METABOLISM (2018)
The Logic of the 26S Proteasome
Galen Andrew Collins et al.
CELL (2017)
Inhibition of Transforming Growth Factor-β Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma
Ailing Lu et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Targeting proteasome ubiquitin receptor Rpn13 in multiple myeloma
Y. Song et al.
LEUKEMIA (2016)
Molecular basis of resistance to proteasome inhibitors in hematological malignancies
Denise Niewerth et al.
DRUG RESISTANCE UPDATES (2015)
Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation
Derek James Hanson et al.
ONCOTARGET (2015)
Proteasome-Mediated Processing of Nrf1 Is Essential for Coordinate Induction of All Proteasome Subunits and p97
Zhe Sha et al.
CURRENT BIOLOGY (2014)
A bis-Benzylidine Piperidone Targeting Proteasome Ubiquitin Receptor RPN13/ADRM1 as a Therapy for Cancer
Ravi K. Anchoori et al.
CANCER CELL (2013)
Therapeutic Advances in Relapsed or Refractory Multiple Myeloma
Kenneth C. Anderson
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2013)
A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
Dharminder Chauhan et al.
CANCER CELL (2012)
Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells
N. E. Franke et al.
LEUKEMIA (2012)
Levels of angiogenic factors in patients with multiple myeloma correlate with treatment response
Ludek Pour et al.
ANNALS OF HEMATOLOGY (2010)
Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease
Anjli Kukreja et al.
BLOOD (2009)
Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target
Dharminder Chauhan et al.
CANCER CELL (2009)
Molecular basis of bortezomib resistance:: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein
Ruud Oerlemans et al.
BLOOD (2008)
Adrm1, a putative cell adhesion regulating protein, is a novel proteasome-associated factor
Jakob Ploug Jorgensen et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
The caspase-like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites
AF Kisselev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A phase 2 study of bortezomib in relapsed, refractory myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
